| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.0094 | 0.9 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |